← Eichor
Condition: Patients With Schizophrenia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Patients With Schizophrenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06505668App and Body Fat Scale in the Management of Overweight Patients
NA · 1 location(s) · Capital Medical University · NCT05866107Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Phase 4 · 1 location(s) · Mayo Clinic · NCT07213466RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NA · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05704582Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis
NA · 1 location(s) · Fundació Sant Joan de Déu · NCT07091344Synbiotic Compound to Reduce Symptoms of Schizophrenia
Phase 2 · 1 location(s) · Sheppard Pratt Health System · NCT04226898Karolinska Schizophrenia Project
Phase N/A · 1 location(s) · Karolinska Institutet · NCT06872463Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.
NA · 1 location(s) · Hôpital le Vinatier · NCT05036590tACS for Working Memory in Schizophrenia
NA · 1 location(s) · Central South University · NCT07701343Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Phase 2 · 2 location(s) · Anders Fink-Jensen, MD, DMSci · NCT06939088Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
Phase 1 · 4 location(s) · Vigonvita Life Sciences · NCT06504290Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or B
NA · 2 location(s) · Vestre Viken Hospital Trust · NCT06197048Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
NA · 1 location(s) · Boston VA Research Institute, Inc. · NCT05299749Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized
Phase N/A · 1 location(s) · Akrivia Health · NCT06641726The Hi-tACS on Cognitive Function in Patients With Schizophrenia
NA · 2 location(s) · Sir Run Run Shaw Hospital · NCT06470516Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · 22 location(s) · Vanda Pharmaceuticals · NCT06961968Patientheque in Patients With a Psychosis
NA · 1 location(s) · University Hospital, Brest · NCT05340348Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
NA · 8 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT04871048Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
NA · 3 location(s) · Centre Hospitalier St Anne · NCT07295652Autonomic Nervous System and Meridian Energy in Patients With Schizophrenia
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06617104VR-based Avatar Therapy for Treatment of Auditory Hallucinations
NA · 4 location(s) · Semmelweis University · NCT06505564Temporal Memory in Schizophrenic Patients
NA · 1 location(s) · Xiaofeng Ma · NCT06562504MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Phase 2/Phase 3 · 3 location(s) · Mclean Hospital · NCT06191965Neuroimmunology Registry and Biobank
Phase N/A · 2 location(s) · Charite University, Berlin, Germany · NCT06958341Virtual Reality and Artificial Intelligence in Treatment for Patients With Psychosis
NA · 2 location(s) · Oslo University Hospital · NCT06728241Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
NA · 5 location(s) · University Hospital, Brest · NCT05384392Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psyc
NA · 1 location(s) · Centre Psychothérapique de Nancy · NCT06036316iTBS for Increased Appetite Induced by Antipsychotics
NA · 2 location(s) · Central South University · NCT05783063Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant
Phase 3 · 10 location(s) · Newron Pharmaceuticals SPA · NCT07184619
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.